D. Tural Et Al. , "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.," Journal of oncological sciences , vol.38, no.6_suppl, pp.1-5, 2020
Tural, D. Et Al. 2020. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.. Journal of oncological sciences , vol.38, no.6_suppl , 1-5.
Tural, D., Olmez, O. F., Sumbul, A. T., Artac, M., Ozhan, N., Akar, E., ... Cakar, B.(2020). Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.. Journal of oncological sciences , vol.38, no.6_suppl, 1-5.
Tural, Deniz Et Al. "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.," Journal of oncological sciences , vol.38, no.6_suppl, 1-5, 2020
Tural, Deniz Et Al. "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.." Journal of oncological sciences , vol.38, no.6_suppl, pp.1-5, 2020
Tural, D. Et Al. (2020) . "Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.." Journal of oncological sciences , vol.38, no.6_suppl, pp.1-5.
@article{article, author={Deniz Tural Et Al. }, title={Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.}, journal={Journal of oncological sciences}, year=2020, pages={1-5} }